Neuropace Inc (NPCE) stock news · rev $100.0M
Neuropace Inc (NPCE) is a medical devices company listed on US.
This NPCE news page leads with what Neuropace Inc filed — not a scraped headline mill.
No cached 8-K sentence for NPCE yet. We will not pad this page with generic market recap.
Latest reported NPCE revenue for 2025-12-31 was $100.0M. Net income was -$21.5M. Revenue was up 25.1% from 2024-12-31 to 2025-12-31. NPCE currently screens at market cap $312.2M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the NPCE stock page; for the tape open the quote page.
NPCE stock news FAQ
What are NPCE's latest revenue and net income?
Latest cached Neuropace Inc (NPCE) revenue for Dec 31, 2025 was $100.0M. Net income was -$21.5M. Statements: https://lician.com/financials/npce
How did NPCE revenue change from the prior cached period?
Cached Neuropace Inc (NPCE) revenue was up 25.1% from $79.9M (Dec 31, 2024) to $100.0M (Dec 31, 2025). Statements: https://lician.com/financials/npce
What is NPCE's market cap?
Neuropace Inc (NPCE) market cap is $312.2M on the latest cached fundamentals snapshot.
What kind of company is NPCE?
Neuropace Inc (NPCE) is a medical devices company listed on US.
Where is NPCE stock news listed?
Cached stock news for Neuropace Inc (NPCE) is listed at https://lician.com/news/npce. Filings: https://lician.com/sec/npce
Not investment advice.